KCT0009000
Not yet recruiting
未知
Efficacy and Safety of 1L Polyethylene Glycol plus Low-dose Ascorbic Acid Compared to D-Sorbitol and Picosulfate plus Ascorbic Acid: Multi-center, randomized, single-blind prospective study
Chung-Ang Univerisity Hospital0 sites200 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Factors influencing health status and contact with health services
- Sponsor
- Chung-Ang Univerisity Hospital
- Enrollment
- 200
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The following are the inclusion criteria for patients eligible to participate in the study:
- •Adult men and women aged 19 years and above.
- •Patients scheduled to undergo colonoscopy for screening or diagnostic purposes at the Gastroenterology outpatient departments of Chung\-Ang University Hospital and Chung\-Ang University Gwangmyeong Hospital from the start of the study.
- •Patients who have provided informed consent to participate in the study.
Exclusion Criteria
- •The following are the criteria for excluding patients from participating in the study:
- •1\. Patients with functional or anatomical gastrointestinal obstructions (such as gastric paresis, pyloric stenosis, functional bowel obstructions, toxic megacolon, etc.), active gastrointestinal bleeding, or intestinal perforation.
- •2\. Patients with dehydration, severe vomiting, or severe diarrhea.
- •3\. Patients with a history of or current inflammatory bowel disease (Crohn's disease or ulcerative colitis) or those strongly suspected of having such conditions.
- •4\. Patients with confirmed gastric ulcers.
- •5\. Patients with a known history of intestinal adhesions that require surgery, or those in an acute abdominal condition requiring surgical intervention.
- •6\. Patients with a history of previous gastrointestinal resection surgery (excluding appendectomy).
- •7\. Patients with a history of glucose\-6\-phosphate dehydrogenase deficiency.
- •8\. Patients with significant cardiovascular diseases (New York Heart Association classification III and IV), respiratory diseases, kidney disease (creatinine clearance \<30mL/min), liver disease, or a combination of these conditions.
- •9\. Patients with dementia, cognitive impairment, or altered consciousness.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Can polyethylene glycol solution be used as an alternative to lactulose in patients of hepatic encephalopathy ?Health Condition 1: F99- Mental disorder, not otherwise specifiedCTRI/2024/02/062513I
Active, not recruiting
Phase 1
Randomized controlled study to assess the efficacy of a very low-volume Polyethylene Glycole (PEG 1L) bowel preparation vs. low-volume (2L) and high-volume (4L) PEG-based preparations, among patients who undergo bowel purge for colonoscopy during in hospital stay.Adult in hospital patients who undergo colonoscopy for any medical diseaseMedDRA version: 21.0Level: PTClassification code 10010007Term: ColonoscopySystem Organ Class: 10022891 - InvestigationsTherapeutic area: Diseases [C] - Digestive System Diseases [C06]EUCTR2019-002799-15-ITALMA MATER STUDIORUM UNIVERSITà DI BOLOGNA800
Recruiting
Phase 3
Comparison of the effect of Polyethylene Glycol (Single dose vs divided dose) in Treatment of Functional Constipation in ChildreConstipation.ConstipationK59.0IRCT20090908002434N9Shiraz University of Medical Sciences80
Completed
Phase 3
Comparison of the effect of polyethylene glycol syrup and lactulose syrup in children aged 1 to 15 years with chronic functional constipatiochronic functional constipation.ConstipationK59.0IRCT20171015036783N2Shahid Beheshti University of Medical Sciences100
Not yet recruiting
Not Applicable
POLYETHYLENEGLYCOL, ELECTROLYTES AND PROBIOTICS IN CONSTIPATION IN CHILDRECTRI/2022/06/043454SHIVAKUMAR NALUBOLA